Play Ball: The Red Sox and Jimmy Fund Start Another Season Together

Their season starts today, and although the Boston Red Sox will have a lot of competition in their quest to repeat as World Series champions, fans can be certain of one thing: a continuation of the baseball team’s special bond with the Jimmy Fund and Dana-Farber Cancer Institute. Dating from 1953, this is the longest and most successful partnership between a professional sports team and charity in North America. The Red Sox have helped the Jimmy Fund raise millions of dollars for cancer care and research at Dana-Farber through appearances and appeals while befriending patients of all ages. Here are …

Continue reading

When is an Antipsychotic Not an Antipsychotic? When it’s an Antileukemic

By Tom Ulrich One of the hot trends in drug discovery could be called drug re-discovery: finding new uses for drugs that have already received FDA approval for a different indication. It’s an approach that allows researchers and clinicians to rapidly test potential treatments for rare or difficult-to-treat conditions. Because the drug’s safety profile is already known, much of the preclinical and early clinical work that goes into developing a drug can be bypassed.

Living Life

By Jack Coates In May 2001, I was diagnosed with medullablastoma. I was 19 years old and had just finished my freshman year at Johnson & Wales University in Rhode Island. Medullablastoma is a cancer that affects the brain and the spine. I had three surgeries, 52 weeks of chemo, and six weeks of radiation. I spent a year and two months in the hospital and went from 217 pounds to 97. I was scared. I was asking God: “Why?  Why did it have to happen to me?” It was shocking. Many things went through my mind.

Do Men and Women Have Different Symptoms of Colorectal Cancer?

While there are slightly more incidences of colorectal cancer in men (71,860 new cases projected in the U.S. in 2014) than women (65,000), both men and women generally exhibit the same symptoms of the disease, according to Jeffrey Meyerhardt, MD, MPH, clinical director of the Center for Gastrointestinal Oncology at Dana-Farber/Brigham and Women’s Cancer Center.

Coping With Cancer Through Creative Expression

A cancer diagnosis brings more than physical challenges. Patients and loved ones must also manage the emotional toll that can come with it. Storytelling, through word, pictures or other creative expression, can be an effective way to deal with these emotions and help with the healing process. Some people look to painting or writing, while others may cope through dance, music, or a tattoo. We want you to share your story with us. Whether it’s a piece of artwork, a blog post, or a small tattoo on your wrist – show us how you coped with a cancer diagnosis. Submit …

Continue reading

Clinical Trials Paving the Way for Improved Vulvar Cancer Treatment

Cancers of the vulva – the external portion of the female genitals – are diagnosed in approximately 4,700 women in the United States each year. While many patients can be cured by a combination of surgery, chemotherapy, and radiation therapy, others – particularly those whose cancer has metastasized to other parts of the body – often don’t fare as well. As one of the rarer forms of gynecologic cancer, vulvar cancer hasn’t attracted as much research funding as other forms. Still, several efforts are under way to make treatment options more effective, according to Neil Horowitz, MD, a vulvar cancer expert …

Continue reading

DNA Test May Offer Alternative to Pap Smear

A Food and Drug Administration (FDA) panel has recommended that a DNA test should be the primary screening tool for cervical cancer, rather than the traditional Pap smear. The DNA test detects the DNA of human papillomavirus (HPV), the sexually transmitted infection that causes almost all cases of cervical cancer. “This is an important step forward for cervical cancer screening,” says Alexi Wright, MD, MPH, a medical oncologist in the Susan F. Smith Center for Women’s Cancers at Dana-Farber. Specifically, the DNA test screens for HPV-16 and HPV-18, the two highest-risk HPV strains, as well as 12 other high-risk HPV …

Continue reading